Compendium of Cancer Genome Aberrations

HAEM5:EBV-positive diffuse large B-cell lymphoma: Difference between revisions

(View all pending changes)
[pending revision][pending revision]
← Older editNewer edit →
VisualWikitext
Line 202: Line 202:
|-
|-
|''TNFAIP3'' (A20) and ''MAP3K14'' (NIK); Inactivating mutations
|''TNFAIP3'' (A20) and ''MAP3K14'' (NIK); Inactivating mutations
|<span class="blue-text">EXAMPLE:</span> Histone modification, chromatin remodeling
|Negative regulation of NF-κB pathway<ref name=":9">{{Cite journal|last=Pasqualucci|first=Laura|last2=Dalla-Favera|first2=Riccardo|date=2018-05-24|title=Genetics of diffuse large B-cell lymphoma|url=https://ashpublications.org/blood/article/131/21/2307/37115/Genetics-of-diffuse-large-Bcell-lymphoma|journal=Blood|language=en|volume=131|issue=21|pages=2307–2319|doi=10.1182/blood-2017-11-764332|issn=0006-4971|pmc=5969374|pmid=29666115}}</ref>
|<span class="blue-text">EXAMPLE:</span> Abnormal gene expression program
|Abnormal and prolonged activation of the NF-κB pathway<ref name=":9" />
|-
|-
|
|
Retrieved from "https://test.ccga.io/index.php/HAEM5:EBV-positive_diffuse_large_B-cell_lymphoma"